Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Outlook for the Predictive Genetic Counselling Market Heading Into 2029?
In recent times, there has been a significant expansion in the market size of predictive genetic counselling. Its growth is projected to increase from $3.60 billion in 2024 to $4.19 billion in 2025 with a compound annual growth rate (CAGR) of 16.4%. Several factors have contributed to the growth experienced in the historic period, including the growing fascination with ancestry and genealogy services, increased use of genetic information for research objectives, surging demand for tests to verify paternity and relationships, a rise in the utilization of pharmacogenomics in the development of drugs, and a widening prevalence of private genetic counselling services.
The market for predictive genetic counselling is predicted to experience a swift escalation in the forthcoming years. It is set to expand to $7.59 billion by 2029, boasting a compound annual growth rate (CAGR) of 16.0%. The predicted surge during the forecast period is driven by factors such as the enhancing role of artificial intelligence in estimating genetic risk, the upswing in employer-backed genetic health schemes, an upsurge in collaborations between genetic firms and healthcare providers, an increase in the access to at-home sample collection kits, and heightened demand for reproductive and preconception genetic counselling. Noteworthy trends in the forecasted period encompass progress in multi-omics methodologies for exhaustive risk evaluation, advanced chatbot-based genetic counselling interfaces, refinement of blockchain for safe sharing of genetic data, innovation in wearable technology associated with genetic health insights, and the development of multilingual platforms for genetic counselling.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27397&type=smp
Which Factors Are Pushing The Predictive Genetic Counselling Market Forward?
The predictive genetic counselling market is expected to flourish, propelled by the increasing prevalence of genetic disorders. These disorders, stemming from changes or defects in an individual’s DNA, impact bodily growth, development, and overall functionality. The surge in these disorders can be attributed to the rising maternal and paternal age, as a later age of conception is generally associated with an increased probability of genetic mutations in the child. Genetic disorders contribute to the expansion of predictive genetic counseling by amplifying the demand for risk assessment services, which aid individuals in understanding their potential to inherit or pass on such disorders. In October 2024, the Cystic Fibrosis Trust, a charity based in the UK, reported that the number of registered cystic fibrosis patients had increased to 11,318 in 2023, a noticeable increase from 11,148 in 2022. Hence, the escalating prevalence of genetic disorders is certainly boosting the predictive genetic counselling market.
Which Segment Held The Largest Share In The Predictive Genetic Counselling Market In 2025?
The predictive genetic counselling market covered in this report is segmented
1) By Service Type: Risk Assessment, Carrier Testing, Predictive Testing, Other Service Types
2) By Mode Of Delivery: In-Person, Online
3) By Application: Consumer Genomics, Breast And Ovarian Cancer, Cardiovascular Screening, Diabetic Screening And Monitoring, Colon Cancer, Parkinsonism Or Alzheimer’s Disease, Urologic Screening Or Prostate Cancer Screening, Orthopedic And Musculoskeletal, Other Applications
4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research And Academic Institutes, Other End-Users
Subsegments:
1) By Risk Assessment: Family History Evaluation, Lifestyle And Environmental Risk Analysis, Polygenic Risk Score Analysis, Hereditary Disease Susceptibility Screening
2) By Carrier Testing: Cystic Fibrosis Carrier Testing, Tay-Sachs Carrier Testing, Fragile X Syndrome Testing, Sickle Cell Carrier Testing, Thalassemia Carrier Screening
3) By Predictive Testing: Breast Cancer Gene 1 (BRCA1) Or Breast Cancer Gene 2 (BRCA2) Mutation Testing, Lynch Syndrome Testing, Huntington’s Disease Testing, Cardiovascular Genetic Risk Testing, Neurological Disorder Prediction Testing
4) By Other Service Types: Pharmacogenomic Testing, Prenatal Genetic Testing, Newborn Genetic Screening, Direct-To-Consumer Genetic Testing, Whole Genome Sequencing For Prediction
How Are Key Trends Driving Expansion In The Predictive Genetic Counselling Industry?
Leading corporations in the predictive genetic counselling industry are directing their focus towards creating innovative solutions like predictive genetic testing services. These services aim to detect early risks of diseases and aid informed clinical decisions. This medical service examines an individual’s DNA to locate genetic variations linked to heightened chances of particular hereditary conditions or future diseases. For instance, Genetic Technologies Limited, a firm providing health testing based on genomics from Australia, rolled out the geneType Risk Assessment test in August 2024. This extraordinaryy genetic-screening tool assesses the chance of an individual developing major conditions like colorectal cancer, breast cancer, ovarian cancer, prostate cancer, coronary artery disease, and type 2 diabetes. The test fuses clinically approved polygenic risk scores with non-genetic elements such as age, clinical measurements, and family history to yield a personalised, actionable risk profile. It’s crafted for proactive health management and offers clear reports with customised recommendations to help guide preventive care and lifestyle decisions in over 42 nations.
Which Organizations Are Driving Progress In The Predictive Genetic Counselling Industry?
Major companies operating in the predictive genetic counselling market are Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Inc., Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN NV, Natera Inc, Myriad Genetics Inc., Fulgent Genetics Inc, Invitae Corporation, 23andMe Holding Co, Color Genomics Inc, deCODE genetics, Centogene NV, Admera Health LLC, Mapmygenome, Exact Sciences Corporation, BGI Group.
Get The Full Report Here:
Which Region Is Expected To Experience The Highest Growth In The Predictive Genetic Counselling Industry?
North America was the largest region in the predictive genetic counselling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive genetic counselling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=27397&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model